Vimarsana
Biggest News Aggregation in the World

Page 4 - Brian Berman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brian Berman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brian Berman Today - Breaking & Trending Today

Deadline Detroit | Starkman: Beaumont Hospital Staffers Horrified After Patient Dies During Routine Colonoscopy - Vimarsana News

Deadline Detroit | Starkman: Beaumont Hospital Staffers Horrified After Patient Dies During Routine Colonoscopy

Share January 25, 2021, 9:29 PM The columnist, a Los Angeles freelancer, is a former Detroit News business reporter who blogs at Starkman Approved. By Eric Starkman The inevitable tragedy Beaumont Health chairman John Lewis and Michigan Attorney General Dana Nessel were warned about occurred last Thursday in the early afternoon: A 51-year-old man walked into the colonoscopy suite at Beaumont’s flagship Royal Oak hospital at 13 and Woodward thinking he’d be undergoing a routine screening and heading home a few hours later. Instead, the patient, the sole caregiver for ...

Sirnaomics Reports Positive Data from Phase 2a Study of STP705 for Treatment of Squamous Cell Skin C - Vimarsana News

Sirnaomics Reports Positive Data from Phase 2a Study of STP705 for Treatment of Squamous Cell Skin C

Search jobs 20-Dec-2020 Sirnaomics Reports Positive Data from Phase 2a Study of STP705 for Treatment of Squamous Cell Skin Cancer GAITHERSBURG, Md. and SUZHOU BIOBAY, China, Dec. 20, 2020 /PRNewswire/ -- Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced positive efficacy and safety results from a Phase 2a clinical study of the company's lead drug candidate, STP705, for treatment of squamous cell skin cancer. The open label, dose escalati...

Sirnaomics Reports Positive Data from Phase 2a Study of STP705 for Treatment of Squamous Cell Skin Cancer - Vimarsana News

Sirnaomics Reports Positive Data from Phase 2a Study of STP705 for Treatment of Squamous Cell Skin Cancer

Press release content from PR Newswire. The AP news staff was not involved in its creation. Sirnaomics Reports Positive Data from Phase 2a Study of STP705 for Treatment of Squamous Cell Skin Cancer December 20, 2020 GMT Sirnaomics' Company Logo (PRNewsfoto/Sirnaomics, Inc.) GAITHERSBURG, Md. and SUZHOU BIOBAY, China, Dec. 20, 2020 /PRNewswire/ -- Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced positive efficacy and safety results from a Phase 2a clinical study of the company’s l...

Source: apnews.com
LSJ staff members look ahead to 2021 hot topics and trends, focus on balanced coverage - Vimarsana News

LSJ staff members look ahead to 2021 hot topics and trends, focus on balanced coverage

LSJ staff members look ahead to 2021 hot topics and trends, focus on balanced coverage Lansing State Journal © Robert Killips | Lansing State Journal Work continues on the 600 block of East Michigan Avenue which includes a Meijer, lofts, and a hotel set to open in 2021 Saturday, Sept. 12, 2020. Predicting news is about as easy as predicting the weather. Some stories, some days are simpler than others. Then there are always surprises. The LSJ team is comprised of 20 journalists covering news across Greater Lansing — Ingham, Eaton and Clinton counties — including news ...

Source: msn.com
Lemonex wins Innovation Winner 2020 with DegradaBALL - Vimarsana News

Lemonex wins Innovation Winner 2020 with DegradaBALL

Lemonex wins Innovation Winner 2020 with DegradaBALL | Lemonex’s chief technology officer Min Dal-hee presents at the 2018 mRNA Healthcare Conference (Lemonex) Lemonex, a South Korean biotherapeutics and biotech company, was acknowledged with an Industry and Energy Ministerial prize for technology innovation at the Innovation Winner 2020 awards. The Innovation Winner 2020 was hosted by Herald Corp. in collaboration with monthly magazine PowerKorea on Thursday. Lemonex won for its original drug delivery technology called DegradaBALL. “DegradaBALL enables effective delivery of various new...